Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTUNG.L Regulatory News (TUNG)

  • There is currently no data for TUNG

Market update

25 Sep 2014 07:27

RNS Number : 5777S
Tungsten Corporation PLC
25 September 2014
 

TUNGSTEN CORPORATION PLC 

 

("Tungsten" or the "Company")

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN NOR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

For Immediate Release 25 September 2014

 

 

Market update

Pharmaceutical and healthcare companies continue to choose Tungsten Network

Seven of the top-twelve global pharmaceutical businesses use the global e-Invoicing network

 

London, 25 September - Tungsten Network is the e-Invoicing provider of choice for the world's leading pharmaceutical and healthcare companies.

The latest organisations to select Tungsten Network include Fresenius Medical Care NA, a US-based provider of kidney dialysis services and renal care products, and Dana-Farber Cancer Institute, a world leader in cancer treatment and research.

These new customers join the global e-Invoicing network alongside long-term practitioners, such as GlaxoSmithKline, and reinforce Tungsten's strength in this industry. Seven of the twelve largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.

"The pharmaceutical sector has been an early adopter of e-Invoicing with our first customer from the industry joining the network in 2004," says Edmund Truell, Tungsten Group CEO. "It's befitting that an industry focused on innovation is equally pioneering in its own business practices."

 

Enquiries:

 

Tungsten Corporation plc

Edmund Truell, Chief Executive Officer +44 20 3435 5680

 

Charles Stanley Securities

(Nominated Adviser and Joint Broker)

Marc Milmo/Dugald Carlean +44 20 7149 6000

 

Canaccord Genuity Limited

(Joint Broker)

Simon Bridges/Peter Stewart/Cameron Duncan +44 20 7523 8000

 

Equus Group (Communications)

Piers Hooper / Sam Barton +44 20 7223 1100

 

About Tungsten Corporation plcTungsten Corporation (LSE: TUNG) accelerates global trade by enabling customers to streamline invoice processing, improve cash-flow management and make better buying decisions from their detailed spend data.

 

Buyer organisations that join Tungsten Network, built on OB10 e-Invoicing, can reduce their invoice-processing costs by 60%. Suppliers benefit from efficiencies, greater visibility of their invoice status and peace of mind. Tungsten offers supply chain financing through Tungsten Bank and helps buying organisations profit by applying real-time spend analytics to its vast repository of line-level invoice data.

 

Tungsten serves 53% of the Fortune 500 and 66% of the FTSE 100 by connecting the world's largest companies and government agencies to their thousands of suppliers around the globe. It is compliant in 46 countries, and last year processed transactions worth over $187bn for organisations such as Alliance Data, Aviva, Cargill, Deutsche Lufthansa, General Motors, GlaxoSmithKline, Henkel, IBM, Kellogg's, and US Federal Government.

 

Tungsten Corporation joined forces with OB10 in 2013 to create the world's largest electronic trading network.

 

Contact: Sandra Higgison, Head of Global Communications, +44 20 7280 7973, sandra.higgison@tungsten-network.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALAMFTMBBTMLI
Date   Source Headline
23rd May 202211:01 amRNSForm 8 (DD) - Tungsten Corporation plc
23rd May 202211:00 amRNSForm 8 (DD) - Tungsten Corporation PLC
23rd May 20228:38 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
23rd May 20227:00 amRNSAcquisition of Tungsten Shares
23rd May 20227:00 amRNSStatement re Revised Offer by Kofax
20th May 20222:47 pmRNSStatement re revised offer announcement by Kofax
20th May 20222:46 pmRNSOffer Update: Change in Recommendation
20th May 20222:35 pmRNSIncreased Recommended Cash Offer for Tungsten
19th May 20222:27 pmRNSStatement re Recommended Cash Offer
19th May 20222:00 pmRNSPosting of Offer Document
19th May 20227:00 amRNSForm 8 (DD) - Tungsten Corporation plc
18th May 20229:45 amRNSStatement re Potential Competing Offerors
18th May 20227:59 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
13th May 202210:00 amRNSAdjournment of Court Meeting & GM for Kofax Offer
13th May 20228:15 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
12th May 20229:03 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
11th May 20228:01 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
10th May 202212:45 pmRNSHolding(s) in Company
10th May 202210:00 amRNSStatement regarding Pagero offer for Tungsten
10th May 20228:53 amRNSForm 8 (DD) - Offeror
10th May 20228:29 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
9th May 20223:03 pmRNSForm 8.3 - Tungsten Corporation PLC
9th May 202210:09 amRNSStatement re rule 2.7 announcement by Pagero
9th May 202210:05 amRNSOffer Update: Change of Recommendation
9th May 202210:00 amRNSRecommended Cash Offer for Tungsten Corporation
9th May 20229:39 amRNSForm 8.3 - Tungsten Corporation PLC
9th May 20228:41 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
4th May 20228:22 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
28th Apr 20224:04 pmRNSTungsten Corporation Plc - deadline clarification
27th Apr 20227:00 amRNSStatement Regarding Acquisition of Kofax
26th Apr 20227:00 amRNSStatement re announcement by Pagero Group AB
25th Apr 20225:30 pmRNSStatement re Publication of Kofax Scheme Document
25th Apr 20223:00 pmRNSPublication of Scheme Document
25th Apr 202210:00 amRNSForm 8.5 (EPT/RI) - Tungsten Corporation PLC
25th Apr 20228:28 amGNWForm 8.5 (EPT/RI) - Tungsten Corporation Plc
22nd Apr 20228:25 amRNSForm 8.3 - Tungsten Corp PLC
21st Apr 20227:00 amRNSRule 2.8 Announcement
20th Apr 202210:32 amRNSForm 8.3 - Tungsten Corporation plc
20th Apr 202210:29 amRNSForm 8.3 - Tungsten corporation plc
14th Apr 20221:25 pmRNSForm 8.3 - TUNGSTEN CORPORATION PLC
14th Apr 20221:18 pmRNSForm 8.3 - Tungsten Corporation PLC
14th Apr 20227:00 amRNSGrant of extension to deadline
11th Apr 20229:57 amRNSForm 8.3 - Tungsten Corporation plc
6th Apr 202210:58 amRNSForm 8.3 - TUNGSTEN CORP PLC
5th Apr 202211:04 amRNSForm 8.3 - TUNGSTEN CORP PLC
5th Apr 20228:31 amGNWForm 8.5 (EPT/RI) Tungsten Corporation Plc
4th Apr 20221:22 pmPRNForm 8.3 - Tungsten Corporation Plc
1st Apr 20221:49 pmPRNForm 8.3 - Tungsten Corporation Plc
1st Apr 20229:26 amRNSForm 8.5 (EPT/RI) - Tungsten Corporation PLC
31st Mar 20229:46 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.